Literature DB >> 6245805

Positive correlation between histological tumor involvement and generation of tumor cell colonies in agarose in specimens taken directly from patients with small-cell carcinoma of the lung.

D N Carney, A F Gazdar, J D Minna.   

Abstract

Twenty-seven specimens for in vitro agarose clonogenicity testing were obtained from 25 patients with small-cell carcinoma of the lung (SCCL). The specimens were obtained from bone marrows, pleural effusions, lymph nodes, and liver biopsies. Colony formation was seen in 14 of 15 specimens that were histologically involved with SCCL, but no colony growth was seen in the 12 patient specimens without histocytopathological evidence of SCCL, including seven bone marrow specimens. Cytological examination of the agarose colonies confirmed their SCCL origin. Colonies reached sizes of 50 to 1000 cells in 7 to 10 days, indicating an in vitro doubling time of less than 24 hr, remarkably shorter than the population doubling times measured in patients. None of the 100 clones picked from these specimens demonstrated the ability to continuously replicate in vitro. These results show an excellent correlation between agarose colony formation and histological tumor involvement and a more rapid in vitro doubling time than that seen in vivo and demonstrate that standard tissue culture conditions do not allow demonstration of a self-renewing stem cell in fresh tumor specimens of SCCL.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6245805

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

1.  Context-dependent function of the deubiquitinating enzyme USP9X in pancreatic ductal adenocarcinoma.

Authors:  Jesse L Cox; Phillip J Wilder; Erin L Wuebben; Michel M Ouellette; Michael A Hollingsworth; Angie Rizzino
Journal:  Cancer Biol Ther       Date:  2014-05-19       Impact factor: 4.742

Review 2.  Studying lung cancer in the laboratory: 1--Development of model systems.

Authors:  R J Fergusson; J F Smyth
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

Review 3.  Human tumor cloning assays: applications in clinical oncology and new antineoplastic agent development.

Authors:  D D von Hoff
Journal:  Cancer Metastasis Rev       Date:  1988-12       Impact factor: 9.264

4.  NADPH oxidase activation is required in reactive oxygen species generation and cell transformation induced by hexavalent chromium.

Authors:  Xin Wang; Young-Ok Son; Qingshan Chang; Lijuan Sun; J Andrew Hitron; Amit Budhraja; Zhuo Zhang; Zunji Ke; Fei Chen; Jia Luo; Xianglin Shi
Journal:  Toxicol Sci       Date:  2011-07-08       Impact factor: 4.849

5.  Tumor cell colonies in bone marrow cultures from patients with small cell carcinoma of the lung.

Authors:  H A Neumann; G W Löhr; A A Fauser
Journal:  Blut       Date:  1984-04

6.  Establishment and morphologic characterization of normal human endometrium in vitro.

Authors:  G M Centola; M Cisar; D R Knab
Journal:  In Vitro       Date:  1984-06

Review 7.  The human tumor colony-forming chemosensitivity assay: a biological and clinical review.

Authors:  E C Bradley; B F Issell; R Hellman
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

8.  Altered growth of a human neuroendocrine carcinoma line after transfection of a major histocompatibility complex class I gene.

Authors:  M E Sunday; K J Isselbacher; S Gattoni-Celli; C G Willett
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

Review 9.  Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy.

Authors:  James P Sullivan; John D Minna; Jerry W Shay
Journal:  Cancer Metastasis Rev       Date:  2010-03       Impact factor: 9.264

10.  Characterization of mutagen-activated cellular oncogenes that confer anchorage independence to human fibroblasts and tumorigenicity to NIH 3T3 cells: sequence analysis of an enzymatically amplified mutant HRAS allele.

Authors:  C W Stevens; T H Manoharan; W E Fahl
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.